Literature DB >> 2051729

Cytokines in fluids from polycystic kidneys.

K D Gardner1, J S Burnside, L W Elzinga, R M Locksley.   

Abstract

We sought evidence of cytokine presence and interleukin-1 beta (IL-1 beta) bioactivity in 104 aerobic culture negative cyst fluids (CFs) from 13 kidneys of 13 patients with symptomatic normal to end-stage autosomal dominant polycystic kidney disease (ADPKD). ELISAs were used to detect IL-1 beta, interleukin-2 (IL-2), tumor necrosis factor alpha (TNF alpha) and stromelysin. Prostaglandin E2 (PGE2) was detected by radioimmunoassay. IL-1 beta was present in 65 of 94 (less than 20 to 419 pg/ml, TNF alpha in 54 of 75 (less than 10 to 73 pg/ml), stromelysin in 18 of 23 (less than 1.0 to 56 ng/ml), IL-2 in 7 of 23 (0.1 to 1.3 ng/ml) and PGE2 in 9 of 10 fluids (0.03 to 0.49 ng/ml). Of 51 fluids with immunoreactive IL-1 beta, 36 were mitogenic for thymocytes. IL-1 beta concentrations correlated directly with those of IL-2; IL-1 beta presence was associated with higher stimulation indices, higher mean concentrations of TNF alpha, IL-2, stromelysin, and PGE2, and with positive endotoxin assays, suggesting activation of the cytokine cascade in vivo. Cytokine, stromelysin and PGE2 concentrations did not correlate with sodium or non-sodium solute concentrations, nor with CF blood, osmolality, or endotoxin activity, indicating that differences in concentrations among fluids could not be explained by differences in water content. These data identify cytokines as candidate contributors to the morbidity and pathogenesis of ADPKD.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2051729     DOI: 10.1038/ki.1991.87

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  32 in total

1.  Inhibition of the P2X7 receptor reduces cystogenesis in PKD.

Authors:  Ming-Yang Chang; Jenn-Kan Lu; Ya-Chung Tian; Yung-Chang Chen; Cheng-Chieh Hung; Yi-Hui Huang; Yau-Hung Chen; Mai-Szu Wu; Chih-Wei Yang; Yi-Chuan Cheng
Journal:  J Am Soc Nephrol       Date:  2011-06-02       Impact factor: 10.121

Review 2.  The hallmarks of cancer: relevance to the pathogenesis of polycystic kidney disease.

Authors:  Tamina Seeger-Nukpezah; Daniel M Geynisman; Anna S Nikonova; Thomas Benzing; Erica A Golemis
Journal:  Nat Rev Nephrol       Date:  2015-04-14       Impact factor: 28.314

Review 3.  Role of chemokines, innate and adaptive immunity.

Authors:  Kurt A Zimmerman; Katharina Hopp; Michal Mrug
Journal:  Cell Signal       Date:  2020-04-20       Impact factor: 4.315

Review 4.  Polycystic kidney disease--a truly pediatric problem.

Authors:  M R Ogborn
Journal:  Pediatr Nephrol       Date:  1994-12       Impact factor: 3.714

Review 5.  Genetic mechanisms and signaling pathways in autosomal dominant polycystic kidney disease.

Authors:  Peter C Harris; Vicente E Torres
Journal:  J Clin Invest       Date:  2014-06-02       Impact factor: 14.808

6.  Identification of targets of IL-13 and STAT6 signaling in polycystic kidney disease.

Authors:  Erin E Olsan; Jonathan D West; Jacob A Torres; Nicholas Doerr; Thomas Weimbs
Journal:  Am J Physiol Renal Physiol       Date:  2018-03-07

Review 7.  Strategies targeting cAMP signaling in the treatment of polycystic kidney disease.

Authors:  Vicente E Torres; Peter C Harris
Journal:  J Am Soc Nephrol       Date:  2013-12-12       Impact factor: 10.121

8.  Effect of dimethyl fumarate on renal disease progression in a genetic ortholog of nephronophthisis.

Authors:  Oliver Oey; Padmashree Rao; Magdalena Luciuk; Carly Mannix; Natasha M Rogers; Priyanka Sagar; Annette Wong; Gopala Rangan
Journal:  Exp Biol Med (Maywood)       Date:  2018-02-13

Review 9.  Autosomal dominant polycystic kidney disease and transplantation.

Authors:  Mariusz Niemczyk; Stanisław Niemczyk; Leszek Paczek
Journal:  Ann Transplant       Date:  2009 Oct-Dec       Impact factor: 1.530

10.  Doxycycline accelerates renal cyst growth and fibrosis in the pcy/pcy mouse model of type 3 nephronophthisis, a form of recessive polycystic kidney disease.

Authors:  Larissa Osten; Marion Kubitza; Anna Rachel Gallagher; Jürgen Kastner; Heike Olbrich; Uwe de Vries; Frieder Kees; Brigitte Lelongt; Stefan Somlo; Heymut Omran; Ralph Witzgall
Journal:  Histochem Cell Biol       Date:  2009-04-21       Impact factor: 4.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.